Evidence map›Paper›PMID 37685997›Full record

ArticleInternational journal of molecular sciences2023

Kana Masuda-Kuroki, Shahrzad Alimohammadi, Anna Di Nardo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kana Masuda-KurokiDepartment of Dermatology, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.ORCID 0000-0003-0425-6858
Shahrzad AlimohammadiDepartment of Dermatology, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.ORCID 0000-0002-4867-9337
Anna Di NardoDepartment of Dermatology, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.ORCID 0000-0002-5575-9968
University of California San Diego · US

Funding

Mast cells in skin innate immune defenseR01AI093957 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DI NARDO, ANNA · 2011 to 2023
$4.6M
NIAID NIH HHS R01 AI093957
6 · The paper itself

Abstract

Recent studies have identified a subtype of the S1P-receptor family called sphingosine-1-phosphate receptor 2 (S1PR2), which plays a crucial role in maintaining the skin barrier. It has been observed that S1PR2 and

Indexed as

Dermatitis, Allergic ContactSkinAnimalsClaudin-1Health StatusMiceSphingosine-1-Phosphate ReceptorsStaphylococcus epidermidisClaudin-1Sphingosine-1-Phosphate Receptors3,4-Dibutoxy-3-cyclobutene-1,2-dione (SADBE)contact dermatitissphingosine 1-phosphatesphingosine 1-phosphate receptor 2Staphylococcus epidermidis

Identifiers

PMID37685997
PMCPMC10487941
OpenAlexW4386167964

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.